ConcertAI’s TeraRecon, a leading provider of AI-powered advanced visualization (AV) and clinical workflow solutions, today announced it has surpassed 2,000 global customers. This milestone underscores the continued acceleration of TeraRecon’s cloud-first SaaS transformation, reflecting strong adoption across clinical imaging domains such as vascular surgery, interventional radiology, and cardiology. It also highlights the success of targeted international expansion strategies designed to address the complex and evolving needs of diverse healthcare markets.
Transforming Imaging Workflows with Cloud-First SaaS
TeraRecon’s cloud-based SaaS model eliminates the need for costly on-premise infrastructure while delivering scalable, consistent access to AI-enabled visualization tools across healthcare institutions of all sizes—from community imaging centers to enterprise health systems. The platform allows organizations to unify imaging strategies across multiple sites while offering subscription-based access for smaller providers seeking to reduce IT overhead.
“Our transformation to a cloud-first SaaS model represents a fundamental evolution in how healthcare providers globally can operationalize advanced imaging and AI workflows to unlock productivity and ultimately provide more access for patients,” said Dhiraj Carumbaya, Senior Vice President and General Manager of ConcertAI’s TeraRecon business.
He added, “By offering managed services that remove the costly burden of maintaining on-premise systems, we are enabling providers to standardize imaging workflows, accelerate clinical decision-making, and drive efficiency and cost reductions across a wide range of care settings.”
Targeted International Expansion
TeraRecon’s impressive customer growth has been further fueled by a refined global commercial strategy. Rather than adopting a broad regional approach, the company prioritizes country-specific execution in key markets including the United Kingdom, Germany, Italy, and Japan. These strategies involve detailed market sizing, engagement with key opinion leaders, and localized demand generation.
A central focus of these international efforts is ensuring compliance with the regulatory requirements and healthcare standards of each country while still leveraging the benefits of cloud delivery. This approach has allowed TeraRecon to successfully introduce its AI-enabled visualization platform to a wide array of healthcare organizations around the world.
Strengthening Strategic Partnerships
The shift to a cloud-first SaaS model has also enabled deeper collaborations with medical image post-processing providers such as 3DR, as well as global medical device manufacturers specializing in vascular implants and structural heart devices. By leveraging TeraRecon’s cloud-based advanced visualization, 3D measurement, and surgical planning tools through managed service agreements, partners can reduce the need to maintain their own infrastructure and accelerate access to new markets.
These collaborations not only streamline clinical workflows but also provide partners with a scalable platform for device sizing, pre-surgical planning, and deployment, enhancing the efficiency and accuracy of procedures while improving patient outcomes.
Positioned for Industry Momentum
The milestone of 2,000 customers comes at a time of significant industry growth. Cloud-based clinical applications are now adopted by more than 65% of healthcare organizations worldwide, reflecting an accelerated shift toward digital transformation. The advanced visualization market itself is projected to expand at a compound annual growth rate (CAGR) of 11.3% over the next five years, while regulatory bodies have approved over 1,200 AI-enabled algorithms for medical imaging.
“These trends underscore the critical role of AI integration as a key enabler of modern imaging workflows,” Carumbaya noted. “Our customer milestone not only reflects global adoption but also validates our strategy of combining SaaS-based visualization with AI-powered solutions to meet the digital transformation imperatives of healthcare organizations.”
As TeraRecon continues to expand internationally and enhance its cloud platform capabilities, it is well-positioned to meet the growing demand for scalable, intelligent imaging solutions. The company’s cloud-first approach provides healthcare providers with a powerful, flexible, and cost-efficient toolset to improve operational efficiency, clinical decision-making, and ultimately, patient care.
With the 2,000-customer milestone, TeraRecon demonstrates both the success of its global strategy and the growing market appetite for cloud-enabled, AI-driven imaging solutions that enhance productivity and clinical outcomes across the healthcare spectrum.
About ConcertAI
ConcertAI is the leader in predictive and generative Al SaaS and real-world data research solutions for healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARAai™ technologies and scientific expertise in partnership with over 46 leading biomedical innovators, 2,000 healthcare providers and medical societies. TeraRecon provides AV, AI and image viewing solutions for medical imaging, including 3D post-processing tools used in radiology, cardiology, neurology and oncology. CancerlinQ® is an initiative of ConcertAI, providing oncology providers with ASCOaligned automated QOPI and ASCO Certified® quality solutions and SmartlinQ™ analytic services. Headquartered in Cambridge, Mass., ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham and Tokyo. For more information, visit us at concertai.com.
